Ahmed, Sulafa, Ruhnau, Philipp
ORCID: 0000-0001-6546-7312, Enticott, Peter G., Fitzgerald, Paul B and Cirstea, Silvia
(2026)
Temporal Interference Stimulation for Deep Brain Circuits in Autism Spectrum Disorder: A Conceptual Roadmap.
Frontiers in Human Neuroscience
.
Full text not available from this repository.
Official URL: https://www.frontiersin.org/journals/human-neurosc...
Abstract
Autism spectrum disorder (ASD) has a highly heterogeneous clinical presentation and underlying neurobiology. Core ASD features, including social communication difficulties and restricted, repetitive behaviours, are linked to distributed cortico-subcortical networks rather than a single brain region. Although non-invasive brain stimulation has been explored in ASD, current methods are predominantly limited to cortical regions and have a limited capacity to specifically engage deeper network nodes. Temporal interference stimulation (TI) is a new non-invasive neuromodulation method that employs two high-frequency electric fields to generate a low-frequency modulating envelope at depth. This Hypothesis and Theory article proposes a conceptual roadmap for exploring whether TI could provide a framework for testing target engagement and potentially modulating deep brain circuits relevant to ASD. The roadmap is developed by integrating current evidence on network-level mechanisms in ASD with theoretical pathways through which TI might influence these circuits. The roadmap identifies four deep or relatively deep nodes implicated in ASD: the amygdala, the cerebellum, the striatum and the thalamus. It reviews how TI may influence these circuits through effects on connectivity, oscillatory dynamics, and excitation–inhibition regulation. The central argument is not that TI should be a current therapy for ASD. Instead, TI could provide a testable framework for investigating deep-circuit target engagement in carefully selected ASD subgroups. The translation should proceed stepwise, beginning with individualised computational modelling, followed by preclinical and physiological validation, and then early human feasibility studies focused on safety, tolerability, target engagement, biomarker sensitivity and clinically meaningful symptom domains. Future studies should link each stimulation target to a specific clinical feature rather than broad syndrome-level outcomes, with early community engagement critical to ensure that research goals and potential therapeutic targets are meaningful to autistic individuals, families, clinicians and other stakeholders. Overall, TI should be considered an early-stage framework for testing deep-circuit modulation in ASD, not a therapeutic approach at this stage.
Repository Staff Only: item control page
Tools
Tools